Table 1 |
||||
|
Baseline characteristics of included patients. |
||||
|
P-value |
||||
|
Baseline characteristics |
TOTAL |
TRAINED |
UNTRAINED |
trained vs. untrained |
|
|
||||
|
Number |
209 |
78 |
131 |
|
|
Female |
80.4% |
79.5% |
80.9% |
|
|
Rheumatoid factor pos. |
55.5% |
52.6% |
57.3% |
|
|
Age (years) |
56.3(12.3) |
54.2 (12.6) |
57.6 (12.0) |
0.06 |
|
Disease duration (years) |
11.4 (9.6) |
11.0 (9.2) |
11.6 (9.9) |
0.66 |
|
PGA (mm) |
28.1 (21.9) |
28.1 (22.4) |
28.0 (21.7) |
0.97 |
|
VAS pain (mm) |
26.2 (21.0) |
26.1 (20.9) |
26.2 (21.2) |
0.99 |
|
EGA (mm) |
12.9 (13.5) |
16.3 (15.7) |
10.8 (11.5) |
0.004 |
|
CRP (mg/dl) |
0.92 (2.0) |
1.0 (1.7) |
0.89 (2.2) |
0.81 |
|
ESR (mm/hr) |
26.2 (22.3) |
28.2 (26.1) |
25.1 (20.1) |
0.38 |
|
HAQ |
0.78 (0.72) |
0.81 (0.74) |
0.77 (0.71) |
0.71 |
|
SJC28 biometrican |
2.4 (3.0) |
3.3 (3.3) |
1.9 (2.7) |
0.001 |
|
TJC28 biometrican |
2.7 (4.5) |
2.4 (4.1) |
2.9 (4.7) |
0.48 |
|
SJC28 physician |
2.4 (1.9) |
3.1 (3.1) |
1.9 (2.7) |
0.004 |
|
TJC28 physician |
3.0 (4.1) |
2.9 (3.7) |
3.0 (4.4) |
0.85 |
|
SJC28 patient |
3.1 (4.3) |
2.7 (3.6) |
3.4 (4.7) |
0.28 |
|
TJC28 patient |
3.4 (5.2) |
3.0 (4.5) |
3.7 (5.6) |
0.33 |
|
CDAI |
9.0 (7.4) |
10.1 (7.9) |
8.4 (7.0) |
0.097 |
|
SDAI |
10.0 (7.8) |
11.1 (8.5) |
9.3 (7.4) |
0.094 |
|
DAS28 |
3.4 (1.1) |
3.4 (1.2) |
3.4 (1.1) |
0.33 |
|
|
||||
|
Data are shown as mean (SD) unless indicated otherwise. CDAI: Clinical Disease Activity Index, CRP: c-reactive protein, DAS28: disease activity score 28, EGA: evaluator global assessment of disease activity, ESR: erythrocyte sedimentation rate, HAQ: health assessment questionnaire, PGA: patient global assessment of disease activity, SDAI: simplified disease activity score, SJC28: swollen joint count, TJC28: tender joint count, VAS: pain visual analogue scale of pain |
||||
|
Radner et al. Arthritis Res Ther 2012 14:R61 doi:10.1186/ar3777 |
||||